Cresco Labs Inc.
CRLBF · OTC
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 842.68M | 407.01M | -84.30M | -212.05M | -0.71 |
| 2023 FY | 770.89M | 329.89M | -87.82M | -175.52M | -0.54 |
| 2024 FY | 724.34M | 364.45M | 107.29M | -74.44M | -0.22 |
| 2025 FY | 667.33M | 309.72M | 99.08M | -137.78M | -0.39 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 1.58B | 996.01M | 119.34M | 670.17M | 627.04M |
| 2023 FY | 1.36B | 930.40M | 103.43M | 682.76M | 505.69M |
| 2024 FY | 1.36B | 967.18M | 137.56M | 639.64M | 474.85M |
| 2025 FY | 1.20B | 943.08M | 90.92M | 583.10M | 339.83M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 18.74M | -86.13M | -67.39M | — | -104.59M |
| 2023 FY | 58.56M | -57.88M | 693.49K | — | -12.99M |
| 2024 FY | 132.48M | -23.49M | 108.99M | — | 35.73M |
| 2025 FY | 74.17M | -35.75M | 38.41M | — | -50.00M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 536.69M | 1.09B | — | — | — |
| 2023 FY | 440.40M | 1.02B | — | — | — |
| 2024 FY | 315.67M | 817.75M | — | — | — |
| 2025 FY | 418.81M | 910.99M | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 163.62M | 83.26M | 16.14M | -16.33M | -0.05 |
| 2025 Q3 | 164.91M | 79.36M | 17.83M | -17.05M | -0.05 |
| 2025 Q4 | 164.04M | 79.56M | 18.20M | -90.32M | -0.27 |
| 2026 Q1 | 149.23M | 69.55M | 14.63M | -12.89M | -0.04 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 1.35B | 986.85M | 146.61M | 630.91M | 444.47M |
| 2025 Q3 | 1.28B | 940.17M | 45.41M | 580.76M | 428.34M |
| 2025 Q4 | 1.20B | 943.08M | 90.92M | 583.10M | 339.83M |
| 2026 Q1 | 1.20B | 957.79M | 63.78M | 588.71M | 337.13M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 8.83M | -13.30M | -4.47M | — | -9.11M |
| 2025 Q3 | 6.16M | -7.56M | -1.39M | — | -71.06M |
| 2025 Q4 | 27.88M | -9.16M | 18.72M | — | 12.29M |
| 2026 Q1 | -5.55M | -7.53M | -13.09M | — | -27.14M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 182.00M | 666.30M | — | — | — |
| 2025 Q3 | 471.79M | 1.01B | — | — | — |
| 2025 Q4 | 418.76M | 910.94M | — | — | — |
| 2026 Q1 | 323.07M | 848.00M | — | — | — |